25 related articles for article (PubMed ID: 12680228)
1. Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells.
He JH; Li BX; Han ZP; Zou MX; Wang L; Lv YB; Zhou JB; Cao MR; Li YG; Zhang JZ
Tumour Biol; 2016 Oct; ():. PubMed ID: 27743381
[TBL] [Abstract][Full Text] [Related]
2. Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score.
Wang Y; Liu XJ; Yao XD
Chin J Cancer Res; 2014 Aug; 26(4):493-500. PubMed ID: 25232225
[TBL] [Abstract][Full Text] [Related]
3. Can p503s, p504s and p510s gene expression in peripheral-blood be useful as a marker of prostatic cancer?
Cardillo MR; Gentile V; Ceccariello A; Giacomelli L; Messinetti S; Di Silverio F
BMC Cancer; 2005 Sep; 5():111. PubMed ID: 16143040
[TBL] [Abstract][Full Text] [Related]
4. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
de Kok JB; Verhaegh GW; Roelofs RW; Hessels D; Kiemeney LA; Aalders TW; Swinkels DW; Schalken JA
Cancer Res; 2002 May; 62(9):2695-8. PubMed ID: 11980670
[TBL] [Abstract][Full Text] [Related]
5. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
Bussemakers MJ; van Bokhoven A; Verhaegh GW; Smit FP; Karthaus HF; Schalken JA; Debruyne FM; Ru N; Isaacs WB
Cancer Res; 1999 Dec; 59(23):5975-9. PubMed ID: 10606244
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
Tao ZH; Mao XL; Wang CH; Chen XD; Yu KY; Weng ZL; Hu YP; Zhang XH; Xie H; Wang OC; Song QT; Li CD; Chen ZG
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768
[TBL] [Abstract][Full Text] [Related]
7. DD3(PCA3) gene expression in cancer and prostatic hyperplasia.
Floriano-Sánchez E; Cárdenas-Rodríguez N; Castro-Marín M; Alvarez-Grave P; Lara-Padilla E
Clin Invest Med; 2009 Dec; 32(6):E258. PubMed ID: 20003831
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
9. Is DD3 a new prostate-specific gene?
Gandini O; Luci L; Stigliano A; Lucera R; Di Silverio F; Toscano V; Cardillo MR
Anticancer Res; 2003; 23(1A):305-8. PubMed ID: 12680228
[TBL] [Abstract][Full Text] [Related]
10. New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.
Schalken JA; Hessels D; Verhaegh G
Urology; 2003 Nov; 62(5 Suppl 1):34-43. PubMed ID: 14607216
[TBL] [Abstract][Full Text] [Related]
11. [The search for better markers for prostate cancer than prostate-specific antigen].
Schenk-Braat EA; Bangma CH
Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1286-90. PubMed ID: 16821452
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropins and prostate cancer: revisited.
Thwaini A; Naase M; Chinegwundoh F; Baithun S; Ghali L; Shergill I; Iles R
Urol Int; 2006; 77(4):289-96. PubMed ID: 17135776
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
